The Imprint of Salivary Secretion in Autoimmune Disorders and Related Pathological Conditions
Overview
Affiliations
Xerostomia is a state of oral dryness associated with salivary gland dysfunction and is induced by stress, radiation and chemical therapy, various systemic and autoimmune diseases, and specific medications. Fluid secretion is interrupted by the stimulation of neurotransmitter-induced increase in cytosolic calcium ([Ca]) in salivary gland acinar cells, prompting the mobilization of ion channels and their transporters. Salivary fluid and protein secretion are principally dependent on parasympathetic and sympathetic nerves. Various inflammatory cytokines allied with lymphocytic infiltration cause glandular damage and Sjogren's syndrome, an autoimmune exocrinopathy associated with hyposalivation. A defect in IPRs, a major calcium release channel, prompts inadequate agonist-induced [Ca] in acinar cells and deters salivary flow. The store-operated calcium entry-mediated Ca movement into the acini activates K and Cl channels, which further opens a water channel protein, aquaporin-5, and triggers the release of fluid secretion from the salivary glands. The cellular mechanism of salivary gland dysfunction and hyposalivation has not yet been elucidated. In this review, we focused mainly on the proteins responsible for deficient saliva, the correlation between inflammation and salivation, autoimmune disorders and other ailments or complications associated with hyposalivation.
Kwon Y, Choi S, Lee Y, Lee J Sci Rep. 2025; 15(1):7498.
PMID: 40032922 PMC: 11876598. DOI: 10.1038/s41598-025-91271-x.
AMY1 gene copy number associated with xerostomia and Sjögren's syndrome: a cross-sectional study.
Stankeviciene I, Puriene A, Brukiene V, Mieliauskaite D, Baekke S, Tommeras B BMC Oral Health. 2025; 25(1):239.
PMID: 39953449 PMC: 11829383. DOI: 10.1186/s12903-025-05595-1.
Lower Serum IL-10 Linked to Oral Manifestations in Diabetes Patients.
Nuraeny N, Widiasta A, Novianti Y, Zakiawati D, Pratidina N, Sufiawati I Diabetes Metab Syndr Obes. 2025; 18():75-83.
PMID: 39802621 PMC: 11725263. DOI: 10.2147/DMSO.S492765.
Aita A, Galozzi P, Zemin F, Principi G, Contran N, Musso G PLoS One. 2024; 19(11):e0314234.
PMID: 39585877 PMC: 11588261. DOI: 10.1371/journal.pone.0314234.
AlShammari A, AlSaleh S, AlKandari A, AlSaqabi S, AlJalahmah D, AlSulimmani W BMC Public Health. 2024; 24(1):2210.
PMID: 39143473 PMC: 11323639. DOI: 10.1186/s12889-024-19681-6.